Sequoia Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Buy |
133,293
+541
| +0.4% | +$9.07K | 0.02% | 440 |
|
|
2025
Q1 | $2.04M | Buy |
132,752
+18,955
| +17% | +$291K | 0.02% | 431 |
|
|
2024
Q4 | $2.51M | Buy |
113,797
+1,417
| +1% | +$31.2K | 0.02% | 361 |
|
|
2024
Q3 | $2.03M | Buy |
112,380
+805
| +0.7% | +$14.5K | 0.02% | 372 |
|
|
2024
Q2 | $1.81M | Buy |
111,575
+826
| +0.7% | +$13.4K | 0.02% | 349 |
|
|
2024
Q1 | $1.56M | Buy |
110,749
+411
| +0.4% | +$5.8K | 0.02% | 374 |
|
|
2023
Q4 | $1.15M | Buy |
110,338
+5,137
| +5% | +$53.6K | 0.01% | 485 |
|
|
2023
Q3 | $1.07M | Buy |
105,201
+827
| +0.8% | +$8.44K | 0.02% | 319 |
|
|
2023
Q2 | $786K | Sell |
104,374
-5,839
| -5% | -$44K | 0.01% | 398 |
|
|
2023
Q1 | $975K | Buy |
110,213
+7,963
| +8% | +$70.5K | 0.02% | 318 |
|
|
2022
Q4 | $933K | Buy |
+102,250
| New | +$933K | 0.02% | 301 |
|
|
2022
Q2 | – | Sell |
-12,690
| Closed | -$119K | – | 678 |
|
|
2022
Q1 | $119K | Buy |
12,690
+1,713
| +16% | +$16.1K | ﹤0.01% | 635 |
|
|
2021
Q4 | $88K | Buy |
+10,977
| New | +$88K | ﹤0.01% | 574 |
|
|
2021
Q1 | – | Sell |
-10,797
| Closed | -$104K | – | 465 |
|
|
2020
Q4 | $104K | Buy |
+10,797
| New | +$104K | ﹤0.01% | 406 |
|
|
2020
Q2 | – | Sell |
-14,025
| Closed | -$126K | – | 399 |
|
|
2020
Q1 | $126K | Buy |
+14,025
| New | +$126K | 0.01% | 340 |
|